Kim Y. Avenell

SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist

G.A. Kennett, Martyn Wood, Fiona Bright et al. · Neuropharmacology · 1997 · 524 citations · Full text

Medicine, Neuroscience, Pharmacology +12

Pharmacological Actions of a Novel, High-Affinity, and Selective Human Dopamine D3 Receptor Antagonist, SB-277011-A

Stephen G. Taylor, Martyn Wood, Nigel Austin et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 288 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Design and Synthesis of <i>trans</i>-<i>N</i>-[4-[2-(6-Cyano-1,2,3,4-tetrahydroisoquinolin-2- yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011):  A Potent and Selective Dopamine D₃ Receptor Antagonist with High Oral Bioavailability and CNS Penetration in the Rat

Geoffrey Stemp, Tracey Ashmeade, Clive L. Branch et al. · Journal of Medicinal Chemistry · 2000 · 129 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor

Martyn Wood, Izzy Boyfield, David J. Nash et al. · European Journal of Pharmacology · 2000 · 64 citations

Medicine, Neuroscience, Pharmacology +15

Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D3 receptor

Nigel Austin, Kim Y. Avenell, Izzy Boyfield et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 22 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15